|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the University of Ottawa Centre for Transfusion Research and the Clinical Epidemiology Program of the Ottawa Health Research Institute (Drs. Hébert and Tinmouth), Ottawa, Canada; and Section of Critical Care Medicine (Dr. Corwin), Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Correspondence to: Paul C. Hébert, MD, Box 201, 501 Smyth Rd, Ottawa, ON, Canada K1H 8L6; e-mail: phebert{at}ohri.ca
Abstract
Transfusion practice has been under great scrutiny over the last 2 decades. The examination of transfusion risks and benefits have been particularly important in the critically ill patient population. This review will examine some of the important controversies still surrounding the use of RBC transfusion in the critically ill patient.
Key Words: critically ill RBC risk transfusion
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |